Endocrinology and Metabolism Research
A section of Biomedicines (ISSN 2227-9059).
Section Information
This Section publishes reviews and original peer-reviewed papers of a high scientific level covering all the aspects of endocrinology and metabolism. Papers aiming to uncover molecular and cellular mechanisms in endocrinology and metabolism are welcome. Topics include but are not limited to gene regulation, cell biology, signaling, mutations, growth factors, cytokines, hormone receptors, hormone action and regulation, developmental endocrinology, genetic endocrinology, endocrine diseases (diabetes, obesity, osteoporosis, hyperthyroidism etc.), and metabolic diseases.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Molecular Mechanisms and Translational Research on Insulin Resistance (Deadline: 30 June 2026)
- The Aging Metabolism: Diabetes, Obesity, and Lifespan Insights (Deadline: 30 June 2026)
- Chronic Heart Failure: From Biomarkers to Targeted Therapies (Deadline: 30 June 2026)
- Advances in Type 2 Diabetes: Insulin Regulation and Therapeutic Strategies (Deadline: 30 June 2026)
- The Role of Iron in Human Diseases (Deadline: 15 July 2026)
- New Diagnostic and Therapeutic Approaches in Diabetic Microvascular Complications, 3rd Edition (Deadline: 31 July 2026)
- Metabolic Diseases—New Markers and Treatment Pathways (Deadline: 31 July 2026)
- Connections Between Diabetes Mellitus, Other Metabolic and Endocrine Dysfunctions and Cardiovascular Pathologies—Third Edition (Deadline: 31 July 2026)
- Molecular Research on Diabetic Retinopathy (DR) (Deadline: 31 July 2026)
- Novel Biomarker and Treatments for Diabetic Neuropathy (Deadline: 31 July 2026)
- Metabolic Disorders and Their Complications: From Molecular Mechanisms to Therapeutic Perspectives (Deadline: 31 August 2026)
- Risk Factors and Molecular Mechanisms in Diabetes and Cardiovascular Complications (Deadline: 31 August 2026)
- The Pleiotropic Effects of Statins: Anti-Inflammatory, Anti-Coagulant, and Anti-Proliferative Properties (Deadline: 31 August 2026)
- Pathology, Complications and Prognosis of Type 1 Diabetes (Deadline: 29 September 2026)
- Recent Advances in Osteoporosis (Deadline: 30 September 2026)
- Obesity and Obesity-Related Pathology (Deadline: 30 September 2026)
- Biomarkers in Metabolic Disorders, Obesity and Type 2 Diabetes Mellitus—2nd Edition (Deadline: 31 October 2026)
- Type 2 Diabetes: Current Progress and Future Challenges (Deadline: 31 October 2026)
- Advances in Molecular and Cellular Mechanisms in Metabolic Bone and Cartilage Disorders (Deadline: 31 October 2026)
- Adipose Tissue Heterogeneity: Bridging Metabolic Health and Clinical Complications (Deadline: 31 October 2026)
- Obesity-Related Gastrointestinal Disorders: Uncovering Mechanisms Behind Cardiometabolic Improvement with Weight Loss (Deadline: 31 October 2026)
- Multisystem Crosstalk in Health and Disease (Deadline: 31 October 2026)
- Eicosanoids and Fatty Acids in Health, Diseases and Therapeutics (Deadline: 15 November 2026)
- Metabolic Dysfunction-Associated Steatotic Disease (Deadline: 25 November 2026)
- Emerging Trends in Reproductive Endocrinology and Pregnancy-Related Disorders (Deadline: 30 November 2026)
- Antioxidants in Treating Obesity and Metabolic Diseases (Deadline: 31 December 2026)
- Endocrine Disrupting Chemicals and Immune System Dysregulation in Human Health and Disease (Deadline: 31 December 2026)
- Endocrine Disruptors Toxicology: From Molecular Mechanisms to Population Health Effects (Deadline: 31 December 2026)
- Endocrine and Metabolic Insights in Chronic Kidney Disease: Mechanisms, Diagnosis, and Treatment (Deadline: 31 December 2026)
- Molecular Insights and Advances in Metabolic Disorders (Deadline: 31 December 2026)
- Advances in Cancer Cell Metabolism and Tumor Microenvironment (Deadline: 31 December 2026)
- Pathophysiology of Fatty Acid Metabolism (Deadline: 31 December 2026)
- Cardiometabolic Diseases: Molecular Biomarkers and Treatment Strategies (Deadline: 31 January 2027)
- Vitamin D: Latest Scientific Discoveries in Health and Disease (Deadline: 31 January 2027)
- Metabolic Regulation of Cardiovascular Biology in Health and Disease (Deadline: 31 January 2027)
- Growth Hormone Disorders and Their Related Diseases: From Pathophysiology to Therapeutic Approaches (Deadline: 25 February 2027)
- Recent Advances in Circadian Rhythms (Deadline: 28 February 2027)
- Beyond BMI: Multidimensional Obesity Phenotypes, Biological Ageing, and Disease Burden (Deadline: 28 February 2027)
- New Insights into Lipid Metabolism in Health and Disease (Deadline: 28 February 2027)
Topical Collection
Following topical collection within this section is currently open for submissions:
